Linked Life Data

3138577

Source:http://linkedlifedata.com/resource/pubmed/id/3138577

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3138577rdf:typepubmed:Citationlld:pubmed
pubmed-article:3138577lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0020663lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0010132lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0003779lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0007412lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:3138577lifeskim:mentionsumls-concept:C0333668lld:lifeskim
pubmed-article:3138577pubmed:issue3lld:pubmed
pubmed-article:3138577pubmed:dateCreated1988-10-20lld:pubmed
pubmed-article:3138577pubmed:abstractTextThe effects of 6-hydroxydopamine lesions of the ventral noradrenergic bundle (VNAB) and of intracerebroventricular 6-hydroxydopamine on hypothalamo-hypophyseal portal blood (HPB) concentrations of arginine vasopressin (AVP), corticotrophin releasing factor (CRF-41), and noradrenaline have been investigated. VNAB lesions and intracerebroventricular 6-hydroxydopamine caused a reduction of HPB CRF-41 concentration, while AVP remained unchanged. HPB noradrenaline concentration was reduced in animals treated with lateral ventricular 6-hydroxydopamine, but was unchanged in VNAB lesioned animals. Our results suggest differential effects of noradrenaline on the release of AVP and CRF-41 into HPB.lld:pubmed
pubmed-article:3138577pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:languageenglld:pubmed
pubmed-article:3138577pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:citationSubsetIMlld:pubmed
pubmed-article:3138577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3138577pubmed:statusMEDLINElld:pubmed
pubmed-article:3138577pubmed:monthAuglld:pubmed
pubmed-article:3138577pubmed:issn0304-3940lld:pubmed
pubmed-article:3138577pubmed:authorpubmed-author:BiswasSSlld:pubmed
pubmed-article:3138577pubmed:authorpubmed-author:TodaHHlld:pubmed
pubmed-article:3138577pubmed:authorpubmed-author:LightmanS LSLlld:pubmed
pubmed-article:3138577pubmed:authorpubmed-author:JessopD SDSlld:pubmed
pubmed-article:3138577pubmed:authorpubmed-author:EcklandD JDJlld:pubmed
pubmed-article:3138577pubmed:issnTypePrintlld:pubmed
pubmed-article:3138577pubmed:day1lld:pubmed
pubmed-article:3138577pubmed:volume90lld:pubmed
pubmed-article:3138577pubmed:ownerNLMlld:pubmed
pubmed-article:3138577pubmed:authorsCompleteYlld:pubmed
pubmed-article:3138577pubmed:pagination292-6lld:pubmed
pubmed-article:3138577pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:meshHeadingpubmed-meshheading:3138577-...lld:pubmed
pubmed-article:3138577pubmed:year1988lld:pubmed
pubmed-article:3138577pubmed:articleTitleDifferential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood.lld:pubmed
pubmed-article:3138577pubmed:affiliationMedical Unit, Charing Cross and Westminster Medical School, Westminster Hospital, London, U.K.lld:pubmed
pubmed-article:3138577pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3138577pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3138577lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3138577lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3138577lld:pubmed